• Deutsch
    • English
  • Deutsch 
    • Deutsch
    • English
  • Einloggen
Dokumentanzeige 
  •   Startseite
  • Medizin
  • Molekulare Medizin
  • Dokumentanzeige
  •   Startseite
  • Medizin
  • Molekulare Medizin
  • Dokumentanzeige
JavaScript is disabled for your browser. Some features of this site may not work without it.

WNT signalling affects cell migration, invasion and the lymphoma-endothelial interplay in Hodgkin Lymphoma

von Franziska Linke
Dissertation
Datum der mündl. Prüfung:2016-06-13
Erschienen:2016-06-23
Betreuer:Prof. Dr. Dieter Kube
Gutachter:Prof. Dr. Holger Bastians
Gutachter:Prof. Dr. Henning Urlaub
crossref-logoZum Verlinken/Zitieren: http://dx.doi.org/10.53846/goediss-5710

 

 

Dateien

Name:Dissertation Franziska Linke.pdf
Size:6.67Mb
Format:PDF
ViewOpen

Lizenzbestimmungen:


Zusammenfassung

Englisch

Classical Hodgkin Lymphoma (cHL) comprises a unique cancer where the microenvironment accounts for 99 % of the whole tumour mass. In cHL dissemination involves functionally neighbouring lymph nodes but the underlying mechanisms for the spread of lymphoma cells are poorly understood. This thesis aims at characterizing cHL cell migration, invasion and pro-angiogenic properties as well as at identifying the underlying oncogenic pathways. Herein, it is shown that cHL cell migration, invasion and adhesion depend on autocrine WNT signalling as revealed by the inhibition of WNT secretion with porcupine inhibitors Wnt-C59/IWP-2 but also by targeting canonical WNT signalling. Time-lapse studies identified an amoeboid type of cell migration modulated by WNT5A as well as by lymphocyte enhancer binding factor 1 (LEF-1) and β-catenin in a 3D cell culture model. Application of recombinant WNT5A, WNT5A overexpression and WNT5A receptor binding inhibition by Box5 affected cHL cell migration. Among the diverse WNT pathways, the WNT5A-FZD5-DVL3-RHOA cascade and basal canonical WNT signalling are regulators of cHL cell motility. In addition to these mechanistic insights into the in vitro role of WNTs, global gene expression data revealed increased WNT5A and LEF-1 expression in primary cHL cells in comparison to normal B-cell subsets and other lymphomas. The pro-angiogenic potential of cHL cells was revealed by sprouting and vascular tube formation assays of endothelial cells. In that context, LEF-1 and β catenin regulated the secreted VEGFA levels of cHL cells. Importantly, VEGFA gene expression is prognostic for cHL. Furthermore, impaired WNT secretion or canonical WNT signalling as well as WNT5A stimulation had an impact on lymphoma development in the chick chorio-allantoic membrane (CAM) assay. The vasculature network was significantly reduced after inhibition of WNT secretion by Wnt-C59 or canonical WNT pathway inhibition. Therefore, a model is proposed where WNT signalling plays an important role in regulating cHL progression-associated processes.
Keywords: WNT; Hodgkin Lymphoma; Migration
 

Statistik

Hier veröffentlichen

Blättern

Im gesamten BestandFakultäten & ProgrammeErscheinungsdatumAutorBetreuer & GutachterBetreuerGutachterTitelTypIn dieser FakultätErscheinungsdatumAutorBetreuer & GutachterBetreuerGutachterTitelTyp

Hilfe & Info

Publizieren auf eDissPDF erstellenVertragsbedingungenHäufige Fragen

Kontakt | Impressum | Cookie-Einwilligung | Datenschutzerklärung
eDiss - SUB Göttingen (Zentralbibliothek)
Platz der Göttinger Sieben 1
Mo - Fr 10:00 – 12:00 h


Tel.: +49 (0)551 39-27809 (allg. Fragen)
Tel.: +49 (0)551 39-28655 (Fragen zu open access/Parallelpublikationen)
ediss_AT_sub.uni-goettingen.de
[Bitte ersetzen Sie das "_AT_" durch ein "@", wenn Sie unsere E-Mail-Adressen verwenden.]
Niedersächsische Staats- und Universitätsbibliothek | Georg-August Universität
Bereichsbibliothek Medizin (Nur für Promovierende der Medizinischen Fakultät)
Robert-Koch-Str. 40
Mon – Fri 8:00 – 24:00 h
Sat - Sun 8:00 – 22:00 h
Holidays 10:00 – 20:00 h
Tel.: +49 551 39-8395 (allg. Fragen)
Tel.: +49 (0)551 39-28655 (Fragen zu open access/Parallelpublikationen)
bbmed_AT_sub.uni-goettingen.de
[Bitte ersetzen Sie das "_AT_" durch ein "@", wenn Sie unsere E-Mail-Adressen verwenden.]